Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fractional CO2 Laser + Tacrolimus vs Tacrolimus in Stable Vitiligo
NCT03535051Completed
- Sponsor
- Kasr Al Ainy Hospital
- Start
- Jan 2015
- Primary completion
- Jan 2017
01
Overview
Open-label trial (2 arms), sponsored by Kasr Al Ainy Hospital. Primary endpoint: Repigmentation at 5 months. Started Jan 2015; status: completed.
Beyond the preview
Go deeper on NCT03535051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03535051.